Katherine Stueland

Chief Executive Officer, Director, GeneDx Holdings Corp.

Bought, 12 months

$0.0M

Sold, 12 months

$11.2M

Companies

Latest trade

Sep 16, 2026

Companies

GeneDx Holdings Corp.Chief Executive Officer, Director −$12.9M

Trades

WGS Sold 10,501 shares at $97.61 $1.0M Sep 16

WGS Sold 3,692 shares at $84.22 $0.3M Sep 9

WGS Sold 10,501 shares at $60.76 $0.6M Jun 16

WGS Sold 3,639 shares at $53.77 $0.2M Jun 9

WGS Sold 2,172 shares at $65.19 $0.1M Apr 29

WGS Sold 46,933 shares at $63.17 $3.0M Mar 26

WGS Sold 17,179 shares at $76.80 $1.3M Mar 16

WGS Sold 3,678 shares at $86.75 $0.3M Mar 9

WGS Sold 25,459 shares at $78.61 $2.0M Mar 4

WGS Sold 1,653 shares at $94.00 $0.2M Jan 29

WGS Sold 10,857 shares at $143.89 $1.6M Dec 16

WGS Sold 3,639 shares at $159.28 $0.6M Dec 9

WGS Sold 2,158 shares at $136.54 $0.3M Oct 29

WGS Sold 12,858 shares at $108.17 · planned $1.4M Sep 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.